Patriot Express Travel at BWI, SEATAC required on-site, rapid COVID-19 testing
On Nov. 1, 2020, the U.S. Department of Defense announced the start of rapid, on-site COVID-19 testing for…
-
-
Brilacidin exhibited potent in vitro antiviral activity against SARS-CoV-2
On Nov. 1, 2020, scientists announced that increasing evidence shows that both natural and synthetic antimicrobial peptides (AMPs),…
-
InBios awarded $12.7M to boost production of two COVID-19 diagnostics
On Oct. 31, 2020, the U.S. Department of Health and Human Services and the U.S. Department of Defense…
-
Innovation Pharma and George Mason University released lab testing results for Brilacidin’s COVID-19 treatment
On Oct. 30, 2020, Innovation Pharma and George Mason University jointly announced completion of extensive laboratory testing supporting…
-
REGN-COV2 IDMC recommended holding enrollment in hospitalized patients with high oxygen requirements
On Oct. 30, 2020, Regeneron announced that it had received a recommendation from the independent data monitoring committee…
-
Icosavax launched COVID-19 vaccine program with preclinical data and $16.5 million in new funding
On Oct. 30, 2020, Icosavax announced the launch of the company’s COVID-19 vaccine program with preclinical data on…
-
HHS and DOD announced $12.7 million contract with InBios to boost US production of rapid COVID-19 tests
On Oct. 30, 2020, the U.S. Department of Defense (DOD), in coordination with the Department of Health and…
-
The CDC issued framework for resuming safe and responsible cruise ship passenger operations
On Oct. 30, 2020, the Centers for Disease Control and Prevention (CDC) introduced a phased approach for the…
-
Kaiser Permanente Research Institute enrolled volunteers in a phase 3 clinical trial to evaluate COVID-19 vaccine
On Oct. 30, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced enrollment of volunteers in a phase…
-
Trials of University of Oxford’s Coronavirus vaccine began in Kenya
On Oct. 30, 2020, the University of Oxford announced that Kenya had joined the global efforts in search…
-
Hologic awarded US Government contract to expand COVID-19 test production capacity
On Oct. 30, 2020, the Department of Defense (DOD), in coordination with the Department of Health and Human…
-
Oxford University began COVID-19 test for individuals without symptoms
On Oct. 29, 2020, the University of Oxford announced a new pilot scheme to assess the use of…
-
Mammoth Biosciences announced agreements targeting high-throughput CRISPR-based SARS CoV-2 test
On Oct. 29, 2020, Mammoth Biosciences announced that it had signed agreements with MilliporeSigma and Hamilton Company targeting…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Vaccine
OncoSec announced FDA clearance of IND application for phase 1 clinical trial of CORVax12 vaccine candidate for COVID-19
On Oct. 29, 2020, OncoSec Medical announced that the U.S. Food and Drug Administration (FDA) had approved the…
-
PerkinElmer COVID-19 test kit receives FDA Emergency Use Authorization for sample pooling
On Oct. 29, 2020, PerkinElmer announced that its New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization…
-
Moderna partnered with Takeda and Government of Japan to supply 50 million doses of mRNA vaccine against COVID-19
On Oct. 29, 2020, Takeda Pharmaceutical announced that it would import and distribute 50 million doses of Moderna’s…
-
UC Berkeley launched pop-up lab to monitor Bay Area sewage for COVID-19
On Oct. 29, 2020, the University of California, Berkeley (UC Berkeley) announced that it had launched a new…
-
Novartis announced collaboration with Molecular Partners to develop DARPin therapies against COVID-19
On Oct. 28, 2020, Novartis and Molecular Partners announced a collaboration in the form of an option and…
-
CVS Health expanded COVID-19 testing services with 1,000 rapid-result test sites
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
-
NIH scientists discovered key pathway in lysosomes that coronaviruses use to exit cells
On Oct. 28, 2020, researchers at the National Institutes of Health (NIH) announced that they had discovered a…
-
Data for Lilly’s bamlanivimab (LY-CoV555) in COVID-19 outpatients published in NEJM
On Oct. 28, 2020, Eli Lilly announced the New England Journal of Medicine had published data from the…
-
Lilly announced agreement with US government to supply 300,000 vials of investigational neutralizing antibody bamlanivimab to fight COVID-19
On Oct. 28, 2020, Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials…
-
Biotechnology | Cardiology | Diagnostics | Disease | Infectious Disease | Medical Device | Therapeutics
Aspirin use best for those with high coronary calcium, low risk of bleeding
On Oct. 28, 2020, University of Texas (UT) Southwestern scientists reported that an X-ray test commonly used to…
-
UK MHRA began rolling review of Moderna’s mRNA COVID-19 vaccine
On Oct. 28, 2020, The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced it had begun the…
-
Aurinia announced European trial to evaluate antiviral activity of Voclosporin in kidney transplant recipients with COVID-19
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
-
Nektar Therapeutics announced phase 1b clinical study to evaluate empegaldesleukin for treatment of patients with COVID-19
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
-
Additional COVID-19 related genes – both helpful and harmful – revealed in massive screen
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
-
Novavax provided phase 3 COVID-19 vaccine clinical development update
On Oct. 27, 2020, Novavax announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19…
-
DOD and HHS awarded $33 million contract to Tecan to establish domestic production of disposable pipette tips
On Oct. 26, 2020, the Department of Defense (DOD), in coordination with the Department of Health and Human…
-
Antibodies co-invented by Scripps Research and IAVI developed as a potential COVID-19 therapy
On Oct. 26, 2020, immunologists at Scripps Research, in partnership with colleagues at the IAVI Neutralizing Antibody Center,…
